cebinabridgecapital.com | Home

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.cebinabridgecapital.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Home \| Cebina Bridge
Description	The Big top of page Fund Rationale The investment objective of the Fund is to provide absolute return to Participating Shareholders by investing in pharmaceutical
Keywords	N/A

Server Information

WebSite	cebinabridgecapital.com
Host IP	23.236.62.147
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

cebinabridgecapital.com Valuation

US$796,448

Last updated: 2023-05-18 07:41:45

cebinabridgecapital.com has Semrush global rank of 13,289,395. cebinabridgecapital.com has an estimated worth of US$ 796,448, based on its estimated Ads revenue. cebinabridgecapital.com receives approximately 91,898 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, cebinabridgecapital.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$796,448
Daily Ads Revenue	US$736
Monthly Ads Revenue	US$22,056
Yearly Ads Revenue	US$264,666
Daily Unique Visitors	6,127
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
cebinabridgecapital.com. 600	A	cebinabridgecapital.com. 600	IP: 23.236.62.147
cebinabridgecapital.com. 3600	NS	cebinabridgecapital.com. 3600	NS Record: ns27.domaincontrol.com.
cebinabridgecapital.com. 3600	NS	cebinabridgecapital.com. 3600	NS Record: ns28.domaincontrol.com.

HtmlToTextCheckTime:2023-05-18 07:41:45

top of page Fund Rationale The investment objective of the Fund is to provide absolute return to Participating Shareholders by investing in pharmaceutical drug discovery and biotech projects in Central and Eastern Europe. Strategic Partnership ENTER Investor Login → The Big Picture CEBINA Bridge Capital has entered into a collaboration agreement – DANUBE LABS – with CEBINA GmbH and Evotec International GmbH for the purpose of identifying and supporting pharmaceutical drug discovery projects originating from universities, research institutes and other entities in Central and Eastern Europe with each project having specially agreed terms between the parties on the split of participation in any successful end product. CEBINA is incorporated in Vienna, Austria and is a biotech incubator and accelerator and product development and research company. CEBINA will be responsible for identifying and assessing drug discovery projects which will be presented to a Joint Steering Committee

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sat, 28 May 2022 08:25:53 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.cebinabridgecapital.com/
strict-transport-security: max-age=3600
Age: 9524
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=uw2-pub-1
X-Seen-By: gv/XVF9HsGpk8A2KWukUzCWfEJXUOf1J0Ah0dFlolkk=,GXNXSWFXisshliUcwO20Naon851uhK6HRsxREnrEO9ZR8anDSO2jdJ1Hu+f2IyhtmuOkfcTSJaUOHlD2KQbqrA==,m0j2EEknGIVUW/liY8BLLhZ4wvHcBCgqBuXgRA8LPTYm++C2XkuTvnlRFg2XiSDL,2d58ifebGbosy5xc+FRalqriDnm3v3r7NW8CyJVXyZWRFP360WId6KfYQnVuo1FZhD9dxhlKDemh3D1tth0cmw==,2UNV7KOq4oGjA5+PKsX47BChUuzMvEKHAre8Xn85A0QR2rxCTgaJ7/K2Kx9jhAfC
Cache-Control: no-cache
X-Wix-Request-Id: 1653726353.069120898561510024
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sat, 28 May 2022 08:25:53 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1653726353.45441417769126692
content-language: en
strict-transport-security: max-age=3600
age: 0
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=euw3; Max-Age=20; Expires=Sat, 28 May 2022 08:26:13 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=euw3
x-seen-by: sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVi/p8x2vQazP+ZzbdlgXQmT,qquldgcFrj2n046g4RNSVIrig9SAqnXW0O7zAzsQkQs=,2d58ifebGbosy5xc+FRalmBFUDUrN0qUDrf2wP38OeqU6YrHon6f//3EXWLYz/lsxmHv8JmZfQswK4rISLAEpKetP2SzWmME6+k4GRsUrxo=,2UNV7KOq4oGjA5+PKsX47L0JCyoRkP8V7O5D5cu3qJ9YgeUJqUXtid+86vZww+nL,7npGRUZHWOtWoP0Si3wDp7Nk23bew5jhhUsb0LqPOFk=,wjXkXN74v+Dcwxj+UalvvpLUTbR69+SX3cCCASh6UWrBM1zlE+60+GKZrc4q58RrBFNjNRTmQgt5BwMmIVG00A==,xTu8fpDe3EKPsMR1jrheEIq3ST2xbAr/R4Ux8dDkPa4=,LoUK8/saGAmOxZWtpubo2trAHdy0FKANPjM8fZZ5pn3cQ0vqAcDw/JX4L7iWRawZUYca+oATmi3051dLAbyhfQ==,xTu8fpDe3EKPsMR1jrheECsFwI5O/8OMmehAyN9L8OU=,xTu8fpDe3EKPsMR1jrheEI9ptUL/L2RV/D7Cp53rQrs=,/a5ccLSK1HEmwPNg/x6Oukj9PRT88mBdMS0Gi1BC0nhcdMky90vEl8kC0gG4tzfIxDmOVXybqhOtwuej19KIjA==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-content-type-options: nosniff
server: Pepyaka/1.19.10

cebinabridgecapital.com Whois Information

Domain Name: CEBINABRIDGECAPITAL.COM
Registry Domain ID: 2643015504_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-09-23T10:47:45Z
Creation Date: 2021-09-23T10:47:45Z
Registry Expiry Date: 2026-09-23T10:47:45Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS27.DOMAINCONTROL.COM
Name Server: NS28.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-05-28T11:09:13Z <<<

cebinabridgecapital.com valuation and analysis